Yahoo Web Search

Search results

1. www.roivant.comRoivant

   www.roivant.com

   • Cached

   Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology.

   • Stock Quote & Chart

     Today's High Today's Low 52 Week High 52 Week Low. Stock...

   • Company Overview

     Roivant was founded in 2014 with the aim to improve the...

     Careers

     · Annual Reports

     · Contact Us

     · Corporate Responsibility

   • Pipeline

     Pipeline | Roivant. We have a broad and differentiated...

   • Our Companies

     New York. 151 W 42nd Street 15th Floor New York, NY 10036...

   • Leadership

     Matt Gline serves as Chief Executive Officer of Roivant...

   • News & Press Releases

     Roivant Sciences sold a subsidiary for $7.1 billion and...

   • Investor Relations

     Roivant's mission is to improve the delivery of healthcare...

   • Events & Presentations

     Roivant 4Q and Fiscal Year 2022 Earnings Call Presentation...

2. en.wikipedia.org › wiki › Roivant_SciencesRoivant Sciences - Wikipedia

   en.wikipedia.org › wiki › Roivant_Sciences

   • Cached

   Roivant Sciences Ltd. is a healthcare company focused on applying technology to drug development and building subsidiary biotech and healthcare technology companies. It was founded in 2014 by Vivek Ramaswamy .

   • Founded: 2014; 9 years ago
   • Revenue: US$61 million (fiscal 2023)

   • Number of employees: 904 (fiscal 2023)

3. finance.yahoo.com › news › roivant-kinevant-sciencesRoivant and Kinevant Sciences Complete Enrollment in RESOLVE ...

   finance.yahoo.com › news › roivant-kinevant-sciences

   • Cached

   Apr 25, 2024 · BASEL, Switzerland & LONDON & NEW YORK, April 25, 2024--Roivant (Nasdaq: ROIV) and Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare...

4. People also ask

   What does Roivant do?

   • Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology.

   Roivant

   www.roivant.com/

   See all results for this question

   Who founded Roivant Sciences?

   • In 2014, Mr. Ramaswamy founded Roivant Sciences — incorporated in the tax haven of Bermuda and backed by nearly $100 million in funding from investors including QVT, a hedge fund that employed Mr. Ramaswamy after college. ^ Loizos, Connie (2018-11-14). "Biotech holding company Roivant Sciences raised $200M in funding at a whopping $7B valuation".

   Roivant Sciences - Wikipedia

   en.wikipedia.org/wiki/Roivant_Sciences

   See all results for this question

   Does Roivant Sciences have a stock buyback?

   • Roivant Sciences sold a subsidiary for $7.1 billion and plans a $1.5 billion stock buyback. Its pipeline includes promising drugs like IMVT-1402, despite some clinical risks. Financially, Roivant is well-capitalized with $6.67 billion in cash against minimal liabilities.

   News & Press Releases | Roivant - Roivant Sciences

   www.roivant.com/about/news

   See all results for this question

   How does Roivant develop transformative medicines and technologies?

   • We develop transformative medicines and technologies by building agile, focused companies called Vants. Roivant was founded in 2014 with the aim to improve the lives of patients by accelerating the development and commercialization of medicines that matter.

   Company Overview | Roivant - Roivant Sciences

   www.roivant.com/about/company

   See all results for this question

5. investor.roivant.com › news-releases › news-releaseRoivant Sciences Announces Close of Business Combination with ...

   investor.roivant.com › news-releases › news-release

   • Cached

   Oct 1, 2021 · Press Release. Roivant Sciences Announces Close of Business Combination with Montes Archimedes Acquisition Corp. and Concurrent PIPE Financing. October 1, 2021 at 8:00 AM EDT. Roivant will begin trading on Nasdaq under the ticker “ROIV” later today.